Nutrien (NYSE:NTR) Stock Price Target Raised at UBS Group

Nutrien (NYSE:NTR) had its price target hoisted by equities researchers at UBS Group from $62.00 to $63.00 in a report issued on Thursday, Benzinga reports. The brokerage currently has a “sell” rating on the stock. UBS Group‘s target price suggests a potential downside of 9.84% from the company’s current price.

Several other research firms have also issued reports on NTR. Royal Bank Of Canada reiterated an “outperform” rating and set a $85.00 price objective on shares of Nutrien in a research note on Friday, September 18th. Freedom Broker decreased their price objective on Nutrien from $78.00 to $76.00 and set a “hold” rating on the stock in a research report on Wednesday. BNP Paribas Exane upgraded Nutrien from a “neutral” rating to an “outperform” rating and set a $80.00 price objective for the company in a report on Tuesday, July 28th. Oppenheimer decreased their price target on shares of Nutrien from $80.00 to $78.00 and set an “outperform” rating for the company in a report on Thursday, October 22nd. Finally, Raymond James Financial cut their price target on shares of Nutrien from $90.00 to $83.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 28th. Sixteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $79.19.

Nutrien Stock Performance

Shares of NYSE NTR traded down $1.78 during trading hours on Thursday, reaching $69.87. The stock had a trading volume of 151,718 shares, compared to its average volume of 2,973,104. The business’s fifty day moving average is $72.64 and its two-hundred day moving average is $71.15. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.41 and a quick ratio of 0.89. The company has a market cap of $33.21 billion, a price-to-earnings ratio of 15.24, a PEG ratio of 0.80 and a beta of 0.67. Nutrien has a twelve month low of $54.52 and a twelve month high of $85.36.

Nutrien (NYSE:NTR) last posted its quarterly earnings results on Wednesday, November 4th. The company reported $0.61 earnings per share for the quarter, missing analysts’ consensus estimates of $0.74 by ($0.13). The business had revenue of $5.69 billion for the quarter, compared to analyst estimates of $5.66 billion. Nutrien had a return on equity of 8.00% and a net margin of 7.78%. The firm’s quarterly revenue was up .9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.97 EPS. As a group, research analysts expect that Nutrien will post 4.53 EPS for the current year.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. Wellington Management Group LLP acquired a new stake in shares of Nutrien during the second quarter worth $654,081,000. Deutsche Bank AG acquired a new stake in Nutrien during the 2nd quarter worth approximately $588,720,000. The Manufacturers Life Insurance Company acquired a new stake in Nutrien in the second quarter valued at $375,178,000. Canada Pension Plan Investment Board bought a new position in Nutrien during the 2nd quarter worth approximately $359,318,000. Finally, BlackRock Inc. acquired a new stake in shares of Nutrien during the second quarter worth $220,942,000. 63.10% of the stock is owned by institutional investors.

Nutrien Company Profile

Nutrien Ltd. is a Canadian agricultural inputs and services company headquartered in Saskatoon, Saskatchewan. Formed in 2018 through the merger of Agrium and Potash Corporation of Saskatchewan, it serves farmers and other customers through fertilizer production and agricultural retail operations. The company produces potash, nitrogen and phosphate fertilizers, which are used to support crop growth. It also sells crop protection products and seeds, and provides growers with agronomic advice and other services.